F. Tsou

Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients

M. Rizzo, E. Levy, J. Mordoh, 2019, Cancer Immunology, Immunotherapy.

Efficacy and Safety of Nivolumab in Previously Treated Patients With Non-Small-cell Lung Cancer: Real World Experience in Argentina.

M. Rizzo, G. Recondo, R. Kowalyszyn, 2020, Clinical lung cancer.

Implementation of a molecular tumour board in LATAM: the impact on treatment decisions for patients evaluated at Instituto Alexander Fleming, Argentina

Yamil D. Mahmoud, J. O. O Connor, C. Pupareli, 2021, Ecancermedicalscience.

Characteristics and outcomes of thymomas in Latin America: Results from over 10 years of experience (CLICaP‐LATimus)

R. Rosell, A. Cardona, O. Arrieta, 2021, Thoracic cancer.

P84.22 Outcomes of TKI Treatment in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Real-World Study in Argentina

M. Rizzo, C. Martín, G. Recondo, 2021 .

Overcoming Resistance to Osimertinib by T790M Loss and C797S Acquisition Using Gefitinib in a Patient With EGFR-Mutant NSCLC: A Case Report

N. Reguart, C. Pupareli, M. R. Girotti, 2022, JTO clinical and research reports.